U.S. patent number 9,271,876 [Application Number 13/919,145] was granted by the patent office on 2016-03-01 for sealing film dressing.
This patent grant is currently assigned to Molnlycke Health Care AB. The grantee listed for this patent is MOLNLYCKE HEALTH CARE AB. Invention is credited to Tomas Fabo, Bengt Soderstrom, Anna Svensby.
United States Patent |
9,271,876 |
Fabo , et al. |
March 1, 2016 |
Sealing film dressing
Abstract
Provided is a film dressing that includes a thin plastic film
coated with an adhesive, and a carrier layer applied on the plastic
film on a side opposite to the adhesive coating. The adhesive
coating has a softness of 10-22 mm and a weight per unit area of 50
g/m.sup.2 or more.
Inventors: |
Fabo; Tomas (Molnlycke,
SE), Soderstrom; Bengt (Molnlycke, SE),
Svensby; Anna (Vastra Frolunda, SE) |
Applicant: |
Name |
City |
State |
Country |
Type |
MOLNLYCKE HEALTH CARE AB |
Goteborg |
N/A |
SE |
|
|
Assignee: |
Molnlycke Health Care AB
(Goteborg, SE)
|
Family
ID: |
34132534 |
Appl.
No.: |
13/919,145 |
Filed: |
June 17, 2013 |
Prior Publication Data
|
|
|
|
Document
Identifier |
Publication Date |
|
US 20130281906 A1 |
Oct 24, 2013 |
|
Related U.S. Patent Documents
|
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
Issue Date |
|
|
11794988 |
Jul 30, 2013 |
8497407 |
|
|
|
PCT/SE2006/000025 |
Jan 9, 2006 |
|
|
|
|
Foreign Application Priority Data
|
|
|
|
|
Jan 11, 2005 [SE] |
|
|
0500061 |
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61F
13/0253 (20130101); A61F 13/023 (20130101); A61L
15/26 (20130101); A61L 15/58 (20130101); A61B
46/00 (20160201); A61L 15/26 (20130101); C08L
75/04 (20130101); A61L 15/58 (20130101); C08L
83/04 (20130101); A61B 2090/062 (20160201); A61B
90/06 (20160201); A61B 46/40 (20160201); A61B
2046/205 (20160201) |
Current International
Class: |
A61F
13/02 (20060101); A61L 15/26 (20060101); A61L
15/58 (20060101) |
Field of
Search: |
;602/48,41-42,52,54-58,51 ;604/313,307,319 ;128/849,888
;424/443,445-449 ;428/702 |
References Cited
[Referenced By]
U.S. Patent Documents
Foreign Patent Documents
|
|
|
|
|
|
|
1222671 |
|
Jun 1987 |
|
CA |
|
200994982 |
|
Dec 2007 |
|
CN |
|
0051935 |
|
May 1982 |
|
EP |
|
0076896 |
|
Apr 1983 |
|
EP |
|
0144891 |
|
Jun 1985 |
|
EP |
|
0300620 |
|
Jan 1989 |
|
EP |
|
0308122 |
|
Mar 1989 |
|
EP |
|
0507459 |
|
Oct 1992 |
|
EP |
|
0690706 |
|
Jan 1996 |
|
EP |
|
0399520 |
|
Nov 1996 |
|
EP |
|
1424088 |
|
Jun 2004 |
|
EP |
|
1557145 |
|
Jul 2005 |
|
EP |
|
1274382 |
|
May 1972 |
|
GB |
|
1280631 |
|
Jul 1972 |
|
GB |
|
2192142 |
|
Nov 1990 |
|
GB |
|
59036608 |
|
Feb 1984 |
|
JP |
|
2710431 |
|
Feb 1998 |
|
JP |
|
440314 |
|
Jul 1985 |
|
SE |
|
510907 |
|
Jul 1999 |
|
SE |
|
526906 |
|
Nov 2005 |
|
SE |
|
WO 80/01139 |
|
Jun 1980 |
|
WO |
|
WO-8911262 |
|
Nov 1989 |
|
WO |
|
WO 93/19710 |
|
Oct 1993 |
|
WO |
|
WO 96/03167 |
|
Feb 1996 |
|
WO |
|
WO 96/09076 |
|
Mar 1996 |
|
WO |
|
WO 98/15312 |
|
Apr 1998 |
|
WO |
|
WO 98/53778 |
|
Dec 1998 |
|
WO |
|
WO 99/61077 |
|
Dec 1999 |
|
WO |
|
WO 99/61078 |
|
Dec 1999 |
|
WO |
|
WO 00/10540 |
|
Mar 2000 |
|
WO |
|
WO 00/74738 |
|
Dec 2000 |
|
WO |
|
WO 00/76440 |
|
Dec 2000 |
|
WO |
|
WO 01/37782 |
|
May 2001 |
|
WO |
|
WO 02/028447 |
|
Sep 2002 |
|
WO |
|
WO 02/083206 |
|
Oct 2002 |
|
WO |
|
WO 03/026541 |
|
Apr 2003 |
|
WO |
|
WO 03/028601 |
|
Apr 2003 |
|
WO |
|
WO 03/079919 |
|
Oct 2003 |
|
WO |
|
WO 2004/018020 |
|
Mar 2004 |
|
WO |
|
WO 03/079920 |
|
May 2004 |
|
WO |
|
WO 2004/047695 |
|
Jun 2004 |
|
WO |
|
WO 2004/108175 |
|
Dec 2004 |
|
WO |
|
WO 2005/007020 |
|
Jan 2005 |
|
WO |
|
WO 2005/009371 |
|
Feb 2005 |
|
WO |
|
WO 2006/046060 |
|
May 2006 |
|
WO |
|
WO 2006/048240 |
|
May 2006 |
|
WO |
|
WO 2006/075950 |
|
Jul 2006 |
|
WO |
|
WO-2006075948 |
|
Jul 2006 |
|
WO |
|
Other References
3M Products website, "Polyethylene Foam Tape 9776", accessed Apr.
9, 2010,
http://products3.3m.com/catalog/us/en001/heaIthcare/medical.sub.--speciaI-
ties/node.sub.--D7B59V8CXGbe/root.sub.--GST1T4S9TCgv/vroot.sub.--GSJ6V2DG1-
8ge/gvel.sub.--GSQGG5PDQSgl/theme.sub.--us.sub.--medicalspecialties.sub.---
3.sub.--0/command.sub.--AbcPageHandler/output.sub.--html. cited by
applicant .
3M, "TEGADERM.TM. and TEGADERM.TM. HP Transparent Dressings",
Product Brochure, 2004, pp. 1-2. cited by applicant .
American Society for Testing and Materials, "ASTM 666-94: Standard
Specification for Austenitic Stainless Steel Sheet, Strip, Plate,
and Flat Bar", Oct. 1994, pp. 1-6. cited by applicant .
Cinar et al., "Blood Viscocity and Blood Pressure: Role of
Temperature and Hyperglycemia," American Journal of Hypertension,
2001; 12:433-438. cited by applicant .
Glatfelter, "Paper: Moisture and Relative Humidity", Glatfelter
Technical Bulletin, Issue 2005-2, Rev. 05/05, pp. 1-12. cited by
applicant .
Handbook of Chemistry and Physics, 76th Edition, 1995, pp. 6-10;
6-155-6-158. cited by applicant .
Harkins, H. et al., "The Surface Tension of Blood Serum, and the
Determination of the Surface Tension of Biological Fluids", The
Journal of Clinical Investigation, 1929, vol. VII, No. 2, pp.
263-281. cited by applicant .
"Hollister Product Parade", advertisement in Journal Drug
Intelligence & Clinical Pharmacy, 1973, pp. 247. cited by
applicant .
"Part 5: Pharmaceutical Manufacturing", Remington: The Science and
Practice of Pharmacy, 21st Edition, Lippincott Williams &
Wilkins Publishers, 2005, pp. 948. cited by applicant .
Pocius, A.V., "The Chemistry and Physical Properties of
Elastomer-Based Adhesives", Adhesion and Adhesives Technology, 2nd
Edition, Hanser Publishers, Cincinnati, 2002, pp. 238-242. cited by
applicant .
Satas, D. eds., "Silicone Pressure Sensitive Adhesives", Handbook
of Pressure Sensitive Adhesive Technology, 2nd Edition 1989, pp.
515-517. cited by applicant .
Tipler, P., "Solids and Fluids", Physics, Worth Publishers, New
York, 1982, pp. 382-384, 390-391. cited by applicant .
Wacker Silicones, "Wacker SilGel.TM. 612", product datasheet, Sep.
2, 2004, pp. 1-3. cited by applicant .
Webpage, "Amazon.com: Remington: The Science and Practice of
Pharmacy (9780781746731): . . . ", retrieved from
http://www.amazon.com/Remington-The-Science-Practice-Pharmacy/dp/07817467-
36 on Jun. 18, 2012, pp. 1. cited by applicant .
Webpage, "Dressings", printout of Patentee's webpage "Tendra
Startpage>Products>Safetac Technology>Dressings" from May
5, 2003 as captured from WayBackMachine, retrieved from
http://web.archive.org/web/20030505042240/http://www.tendra.com/item.asp?-
id=. cited by applicant .
Webpage, "Internet google book search re: hollister medical
adhesive dressings", retreived from
http://www.r.google.com/search?q=hollister+medicain+silicone+adhesive&btn-
G=Searc . . . on Jun. 18, 2012, pp. 1-2. cited by applicant .
Webpage, "Plastic Material Data Sheet (Knovel) about Dow Coming
7355 silicone adhesive", undated reference, pp. 1. cited by
applicant .
Webpage, "Polydimethylsiloxane", retrieved from
http://en.wikipedia.org/wiki/Polydimethylsiloxane on Jun. 6, 2012,
pp. 1-5. cited by applicant .
Webpage, "Safetac technology", printout of Patentee's webpage
"Tendra Startpage>Products>Safetac Technology" from Apr. 29,
2003 as captured from WayBackMachine, retrieved from
http://web.archive.org/web/20030429170256fw.sub.--/http://tendra.com/item-
.asp?id=1015&lang=2 on Jun. 18, 2012, pp. 1-7. cited by
applicant .
Webpage, screenshots of Patentee's webpage "Tendra
Startpage>Products>Safetac Technology>Silicone" from May
5, 2003 as captured by the WayBackMachine, undated reference, pp.
1-2. cited by applicant .
Amendment after Notice of Allowance (Rule 312) filed on May 30,
2013 for U.S. Appl. No. 11/794,988, filed Oct. 24, 2007
(Inventor--T. Fabo et al.; Applicant--Molnlycke Health Care AB; pp.
1-6). cited by applicant .
Notice of Allowance issued on Apr. 3, 2013 for U.S. Appl. No.
11/794,988, filed Oct. 24, 2007 (Inventor--T. Fabo et al.;
Applicant--Molnlycke Health Care AB; pp. 1-10). cited by applicant
.
Notice of Allowance issued on Aug. 17, 2012 for U.S. Appl. No.
11/794,988, filed Oct. 24, 2007 (Inventor--T. Fabo et al.;
Applicant--Molnlycke Health Care AB; pp. 1-9). cited by applicant
.
Decision to grant European patent issued on Sep. 1, 2011 for EP
Pat. App. No. 06700864.9, national phase of Intl. App. No.
PCT/SE2006/000025, filed on Jan. 9, 2006 (Inventor--T. Fabo et al.;
Applicant--Molnlycke Health Care AB; pp. 1-8). cited by applicant
.
Extended European Search Report with Written Opinion issued May 6,
2010 for EP Pat. App. No. 06700864.9, national phase of Intl. App.
No. PCT/SE2006/000025, filed on Jan. 9, 2006 (Inventor--T. Fabo et
al.; Applicant--Molnlycke Health Care AB; pp. 1-8). cited by
applicant .
Intention to grant European patent issued on Apr. 14, 2011 for EP
Pat. App. No. 06700864.9, national phase of Intl. App. No.
PCT/SE2006/000025, filed on Jan. 9, 2006 (Inventor--T. Fabo et al.;
Applicant--Molnlycke Health Care AB; pp. 1-39). cited by applicant
.
Notice of Opposition filed by Third Party on Jun. 21, 2012 for EP
Pat. No. 1845912, national phase of Intl. App. No.
PCT/SE2006/000025, filed on Jan. 9, 2006 (Inventor--T. Fabo et al.;
Applicant--Molnlycke Health Care AB; pp. 1-27). cited by applicant
.
Notice of Opposition filed by Third Party on Jun. 28, 2012 for EP
Pat. No. 1845912, national phase of Intl. App. No.
PCT/SE2006/000025, filed on Jan. 9, 2006 (Inventor--T. Fabo et al.;
Applicant--Molnlycke Health Care AB; pp. 1-12). cited by applicant
.
Preliminary Amendment and Response filed on Nov. 25, 2010 for EP
Pat. App. No. 06700864.9, national phase of Intl. App. No.
PCT/SE2006/000025, filed on Jan. 9, 2006 (Inventor--T. Fabo et al.;
Applicant--Molnlycke Health Care AB; pp. 1-38). cited by applicant
.
Response to Notices of Opposition filed by Applicant on Nov. 30,
2012 for EP Pat. No. 1845912 (EP App. No. 06700864.9), national
phase of Intl. App. No. PCT/SE2006/000025, filed on Jan. 9, 2006
(Inventor--T. Fabo et al.; Applicant--Molnlycke Health Care AB; pp.
1-39). cited by applicant .
International Search Report with Written Opinion issued on Apr. 27,
2006 for Intl. App. No. PCT/SE2006/000025, filed on Jan. 9, 2006
(Inventor--T. Fabo et al.; Applicant--Molnlycke Health Care AB; pp.
1-7). cited by applicant .
International Preliminary Report on Patentability issued on Jul.
17, 2007 for Intl. App. No. PCT/SE2006/000025, filed on Jan. 9,
2006 (Inventor--T. Fabo et al.; Applicant--Molnlycke Health Care
AB; pp. 1-5). cited by applicant .
Final Office Action issued on Jul. 23, 2012 for U.S. Appl. No.
12/305,590, filed Feb. 20, 2009 (Inventor--A. Svensby; pp. 1-36).
cited by applicant .
Non-Final Office Action issued on Sep. 30, 2011 for U.S. Appl. No.
12/305,590, filed Feb. 20, 2009 (Inventor--A. Svensby et al.; pp.
1-22). cited by applicant .
Preliminary Amendment filed on Dec. 18, 2008 for U.S. Appl. No.
12/305,590, filed Feb. 20, 2009 (Inventor--A. Svensby et al.; pp.
1-12). cited by applicant .
Response to Non-Final Office Action filed on Feb. 29, 2012 for U.S.
Appl. No. 12/305,590, filed Feb. 20, 2009 (Inventor--A. Svensby et
al; pp. 1-19). cited by applicant .
Extended European Search Report with Written Opinion issued for EP
Pat. App. No. 07769030.3, national phase of Intl. App. No.
PCT/SE2007/050484, filed on Jul. 2, 2007 (Inventor--A. Svensby et
al.; Applicant--Molnlycke Health Care AB; pp. 1-4). cited by
applicant .
International Search Report with Written Opinion issued on Oct. 15,
2007 for Intl. App. No. PCT/SE2007/050484, filed on Jul. 2, 2007
(Inventor--A. Svensby et al.; Applicant--Molnlycke Health Care AB;
pp. 1-7). cited by applicant .
International Preliminary Report on Patentability issued on Jan.
13, 2009 for Intl. App. No. PCT/SE2007/050484, filed on Jul. 2,
2007 (Inventor--A. Svensby et al.; Applicant--Molnlycke Health Care
AB; pp. 1-7). cited by applicant .
International Search Report with Written Opinion issued on May 13,
2008 for Intl. App. No. PCT/SE2007/050514, filed on Sep. 6, 2007
(Inventor--Svensby et al.; Applicant--Molnlycke Health Care AB; pp.
1-10). cited by applicant .
International Preliminary Report on Patentability issued on Mar. 9,
2010 for Intl. App. No. PCT/SE2007/050514, filed on Sep. 6, 2007
(Inventor--Svensby et al.; Applicant--Molnlycke Health Care AB; pp.
1-6). cited by applicant .
International Search Report issued on Dec. 15, 2011 for
International Patent Application No. PCT/SE2011/051083, which was
filed on Sep. 7, 2011 [Inventor--Kelvered; Applicant--Molnlycke
Health Care AB] [7 pages]. cited by applicant .
International Preliminary Report on Patentability issued on Mar.
12, 2013 and Written Opinion issued on Dec. 15, 2012 for
International Patent Application No. PCT/SE2011/051083, which was
filed on Sep. 7, 2011 [Inventor--Kelvered; Applicant--Molnlycke
Health Care AB] [13 pages]. cited by applicant .
Australian Office Action dated Jul. 29, 2010 in corresponding
2006205242. cited by applicant .
Opposition Appeal Submission filed Feb. 14, 2014 for EP Pat. No.
1845912, national phase of Intl. App. No. PCT/SE2006/000025, filed
on Jan. 9, 2006 (Inventor--T. Fabo et al.; Applicant--Molnlycke
Health Care AB; pp. 1-61). cited by applicant .
Submission filed Feb. 3, 2014 for EP Pat. No. 1845912, national
phase of Intl. App. No. PCT/SE2006/000025, filed on Jan. 9, 2006
(Inventor--T. Fabo et al.; Applicant--Molnlycke Health Care AB; pp.
1-85). cited by applicant .
Grounds for Appeal as filed Nov. 27, 2013 for EP Pat. No. 1845912,
national phase of Intl. App. No. PCT/SE2006/000025, filed on Jan.
9, 2006 (Inventor--T. Fabo et al.; Applicant--Molnlycke Health Care
AB; pp. 1-19) (Working Translation). cited by applicant .
Grounds for Decision issued Oct. 7, 2013 for EP Pat. No. 1845912,
national phase of Intl. App. No. PCT/SE2006/000025, filed on Jan.
9, 2006 (Inventor--T. Fabo et al.; Applicant--Molnlycke Health Care
AB; pp. 1-11). cited by applicant .
Interlocutory Decision in Opposition Proceedings issued Sep. 27,
2013 for EP Pat. No. 1845912, national phase of Intl. App. No.
PCT/SE2006/000025, filed on Jan. 9, 2006 (Inventor--T. Fabo et al.;
Applicant--Molnlycke Health Care AB; pp. 1-30). cited by applicant
.
Final Submissions filed Aug. 19, 2013 for EP Pat. No. 1845912,
national phase of Intl. App. No. PCT/SE2006/000025, filed on Jan.
9, 2006 (Inventor--T. Fabo et al.; Applicant--Molnlycke Health Care
AB; pp. 1-110). cited by applicant.
|
Primary Examiner: Hawthorne; Ophelia A
Attorney, Agent or Firm: Ballard Spahr LLP
Parent Case Text
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a continuation of application Ser. No.
11/794,988, filed in the U.S. on Oct. 24, 2007, which is a U.S.
National Phase Application of International Application No.
PCT/SE2006/000025, filed Jan. 9, 2006, which International
Application claimed priority to Swedish Patent Application No.
0500061-7, filed Jan. 11, 2005, all of which applications are
incorporated herein fully by this reference.
Claims
The invention claimed is:
1. A film dressing comprising: a thin plastic film coated with an
adhesive; and a carrier layer applied on the plastic film on a side
opposite to the adhesive coating, wherein the adhesive coating has
a softness of 10-22 mm and a weight per unit area that makes the
film dressing leakproof in accordance with MHC Leakage Test with a
groove depth of 75 micrometers, wherein the plastic film has a
thickness of less than 50 micrometers.
2. The film dressing of claim 1, wherein the adhesive coating
comprises a silicone elastomer.
3. The film dressing of claim 2, wherein the adhesive coating
further comprises ZnO.
4. The film dressing of claim 2, wherein the adhesive coating
further comprises a skin care substance.
5. The film dressing of claim 2, wherein the adhesive coating
further comprises a bactericidal substance.
6. The film dressing of claim 1, wherein the adhesive coating
comprises a hot-melt adhesive.
7. The film dressing of claim 6, wherein the adhesive coating
further comprises ZnO.
8. The film dressing of claim 6, wherein the adhesive coating
further comprises a skin care substance.
9. The film dressing of claim 6, wherein the adhesive coating
further comprises a bactericidal substance.
10. The film dressing of claim 1, wherein the plastic film has a
thickness of 12-25 micrometers.
11. The film dressing of claim 10, wherein the plastic film has a
bending rigidity of less than 3 mm.
12. The film dressing of claim 10, wherein the plastic film has a
bending rigidity of less than 1.8 mm.
13. The film dressing of claim 1, wherein a strength of adhesion to
steel of an applied film dressing does not vary by more than 5%
during a period from 1 minute to 48 hours.
14. The film dressing of claim 1, wherein the film dressing is
leakproof on skin.
15. The film dressing of claim 1, wherein the adhesive coating
exhibits a strength of adhesive attachment of at least 0.2 N/25
mm.
16. The film dressing of claim 1, wherein the adhesive coating
exhibits a strength of adhesive attachment of from 0.2 N/25 mm to
3.0 N/25 mm.
17. The film dressing of claim 1, wherein the adhesive coating has
a weight per unit area from 50 g/m.sup.2 to 550 g/m.sup.2.
Description
TECHNICAL FIELD
The present invention relates to a film dressing comprising a thin
plastic film coated with an adhesive.
BACKGROUND ART
At the start of the 1980s, a new type of wound dressing was
launched by Smith & Nephew, a company which manufactures wound
dressing products. The product, which is still on the market and is
sold under the name OpSite.TM., is based on an invention that is
described in British patent GB 1280631. The dressing consists of a
very thin polyurethane film, ca 25 micrometers, that is coated with
a thin, self-adhesive layer of adhesive, also ca 25 micrometers.
Due to its thinness, the film is very flexible and pliant. It can
be attached securely and can seal relatively tightly around wounds
on non-smooth skin surfaces, both convex and concave. Any wrinkles
that are formed, however, sometimes produce thin channels, through
which fluid is able to leak. This dressing, which was totally
unlike all previous dressing products, formed an entirely new
category known as self-adhesive film dressings. More companies
followed with similar products, and today large numbers of film
products with a similar function and characteristics are available
on the market. These film dressings soon found an important
application for the securing and protection of intravenous cannulas
(for example of the Venflon cannula type). They are also used to
cover different types of wound, for example sites from which skin
is removed in conjunction with skin transplantation.
A significant factor for the major sales success of the film
products was, apart from the above-mentioned characteristics, the
successful development of effective application systems. The thin
dressings are extremely difficult to handle without specially
designed application systems. For this purpose, therefore, a more
rigid carrier material is normally attached in a removable fashion
to the non adhesive-coated side of the film in order to impart
rigidity to the product, which would otherwise easily become
tangled up in conjunction with its application to the skin. The
carrier material, which imparts rigidity to the thin film, is not
removed from the product until the self-adhesive film has been
applied in the intended place.
The film dressings have been improved in a variety of ways in more
recent times. Specially designed intravenous securing films have
been developed with a perforated narrow slot to leave space for the
tube connection of the intravenous cannula and, in so doing, to
improve its function. A number of film dressings have been provided
with a wound pad which covers the central part of the
adhesive-coated side (a so-called island dressing), so that a
certain degree of absorption of fluid from the wound is achieved
when the film dressing is applied over a wound.
The above-mentioned category of dressing, self-adhesive film
dressings, has nevertheless shown itself to have a number of
weaknesses:
1. Relatively aggressive adhesives have been used in order to
achieve a secure fixing without the risk of the film dressings
becoming loose. The manufacturers selected aggressive types of
adhesive in order to satisfy themselves that the dressings are
already attached to the skin sufficiently securely immediately
after application. The reason for this is to avoid the intravenous
cannula becoming loose inadvertently, which would constitute a risk
to the safety of the patient. It is also wished to avoid wound
fluid from weeping wounds penetrating the adhesive joint between
the film and the skin and leaking out onto the healthy skin outside
the dressing. The types of adhesive used today possess the
characteristic that the adhesion to the skin increases
substantially with time. The adhesive strength of many film
dressings is multiplied several times over after a few hours or
days, compared with the adhesion immediately after application.
When film dressings are attached too strongly, they often cause
reddening and pain when they are removed from the skin. They also
damage the barrier function of the skin because they take with them
epithelial cells from the skin. In spite of this, a manufacturer
may select these types of adhesive because the most important
consideration is for the adhesion to be sufficiently good directly
after application.
2. In the course of examining the protection against leakage from
film dressings, the applicants identified an unexpected weakness in
the ordinary film dressings. Studies under the microscope revealed
that fluids are capable of spreading easily under the film
dressings, in spite of the fact that they are apparently securely
attached to the skin with an entirely tight seal. It was found that
fluid was capable of spreading for a number of centimeters under
the dressings via the naturally occurring microscopic folds in
normal skin. Because the leakage consists of very small quantities
and is not visible if the inward leakage of colourless fluids is
examined, this has been disregarded previously. The phenomenon,
known as micro-leakage, was first observed when the fluid was dyed
with a strongly coloured pigment. The transport of fluids beneath
the film dressings can constitute a major risk to patients because
micro-organisms could be transported from outside or from the skin
under the dressing and into the wound. An infection from a central
venous catheter (CVC), which will often have been covered with a
film dressing, can constitute a risk to the patient's life.
Manufacturers of film dressings often market these as "shower
proof". When taking a shower, the risk of the aforementioned type
of micro-leakage naturally increases considerably.
3. The adhesive on the film dressings that are sold today exhibits
high adhesion to hairs. Because these dressings are often applied
to hairy skin surfaces, pain and pulling out of hairs often occurs
when the dressings are removed.
The object of the present invention is to solve the aforementioned
problems while retaining all the advantages offered by the thin
elastic carrier material, such as their softness and pliability,
which is the unique strong feature of the film dressing product
type.
DISCLOSURE OF INVENTION
This object is achieved by means of a film dressing comprising a
thin plastic film coated with an adhesive, characterized in that
the adhesive has a softness of 10-22 mm, and in that the adhesive
coating has a weight per unit area of 50 g/m.sup.2 or more. Micro
leakage is prevented by the fact that the adhesive coating has a
high weight per unit area and the adhesive has high softness. Soft
adhesives also exhibit the right level of adhesion directly after
application, and the adhesion increases either not at all or only
slightly with time. Adhesion to hairs is also so low that the hairs
remain in place almost without exception.
In a preferred illustrative embodiment, the adhesive consists of a
silicon elastomer or, alternatively, a hot-melt adhesive.
The film dressing is also leakproof in accordance with the MHC
Leakage Test with a groove depth of 75 micrometers.
The thickness of the plastic film is less than 50 micrometers. The
plastic film preferably has a thickness of 12-25 micrometers and a
bending rigidity of less than 3 mm, and preferably less than 1.8
mm.
The strength of adhesion to steel of an applied dressing preferably
does not vary by more than 5% during the period from 1 minute to 48
hours.
BRIEF DESCRIPTION OF DRAWINGS
The invention is described below with reference to the accompanying
Figures, in which:
FIG. 1 illustrates schematically a cross-sectional view through a
film dressing in accordance with a preferred embodiment of the
invention;
FIG. 2 illustrates schematically the measurement of the strength of
adhesion to the skin;
FIG. 3 shows a cone used for softness measurement;
FIG. 4 illustrates a method of measurement for measuring
softness;
FIGS. 5-11 illustrate the MHC Leakage Test;
FIGS. 12-14 illustrate a method of measuring the bending rigidity
of a plastic film;
FIGS. 15-17 illustrate a method for measuring the adhesion to
steel;
FIG. 18 shows the result of the MHC Leakage Test, and
FIG. 19 shows the adhesive strength as a function of the time for a
plurality of dressings.
MODE(S) FOR CARRYING OUT THE INVENTION
Illustrated in FIG. 1 is a cross-sectional view of a film dressing
1 in accordance with a preferred embodiment of the invention. The
dressing consists of a thin plastic film layer 2 preferably made of
polyurethane plastic, which is coated with a layer 3 of a soft,
skin friendly adhesive. The thickness of the plastic film
preferably lies between 12 and 25 micrometers, and is less than 50
micrometers in any case. The weight per unit area of the adhesive
layer is equal to or greater than 50 g/m.sup.2.
The plastic film also has a bending rigidity of less than 3 mm, and
preferably less than 1.8 mm, measured using a method as described
below.
A carrier layer 4 is also applied above the film layer 2, that is
to say on the side facing away from the adhesive layer 3, in order
to facilitate application of the film dressing. The function of the
carrier layer is to stiffen up the film dressing comprising an
adhesive-coated thin plastic film, and the carrier layer can
consist of, for example, a polyethylene film or a
polyethylene-coated paper with the polyethylene layer facing
towards the film, and with a thickness of 50-300 micrometers. The
adhesive layer 3 is protected in a customary fashion by a
protective layer 5,6 of a material with low adhesion to the
adhesive, for example a polyethylene-coated paper or a polyethylene
film.
The carrier layer 4 is preferably co-extruded together with the
film, or the film may be formed on the carrier layer.
In conjunction with the application of the film dressing 2,3, the
protective layer 5 is first removed, after which the dressing is
positioned on the user's skin. The protective layer 6 is then
removed, and that part of the dressing that was attached to the
layer 6 is pressed securely onto the skin. Finally, the carrier
layer 4 is removed.
The bending rigidity of the plastic film is determined by the
method described below. As shown in FIGS. 12 and 13, in a view
respectively from the front and from the side, a test test piece
FS, having dimensions of 15.times.120 mm, is hung over the edge of
a 0.3 mm thick metal sheet. The ends of the test piece FS are
reinforced with pieces R of two-sided adhesive tape and copying
paper having dimensions of 15.times.40 mm (weight=0.13 g); see FIG.
14. It is important for the sample to be hung over the metal sheet
in such a way that the sample hangs down by the same amount on both
sides of the metal sheet. After 30 seconds, a picture of the sample
hanging as shown in FIG. 12 is taken with a digital camera. A
calibrated ruler is appropriately positioned so that it is included
in the photograph. The bending rigidity is then determined from the
photograph that has been taken by measuring the distance between
the ends of the sample at a point 5 mm below the topmost part of
the sample. The greater the distance between the ends of the
sample, the higher is the bending rigidity exhibited by the sample
FS. In order for the plastic film together with the soft adhesive
to be capable of following all unevennesses in the skin, the
bending rigidity of the film must be less than 3 mm, and must
preferably be less than 1.8 mm.
A principal function of the adhesive coating 3 is to attach the
film dressing 1 tightly to the skin of the patient, so that the
fluid-borne transport of bacteria between the skin and the adhesive
coating is prevented, and to attach the film dressing securely to
the skin, so that the product remains in place during all the
normal loadings to which film dressings are subjected.
The adhesive in the coating must also be skin friendly and must
permit removal of the film dressings without causing damage to the
skin. This requirement presents a major problem in the case of
those types of pressure-sensitive adhesive that are currently used
as adhesive coatings for film dressings. Such adhesives often
attach themselves to the skin so strongly that parts of the Stratum
Corneum, that is to say the uppermost layer of the skin, become
stuck to the adhesive and are pulled away from the skin when the
attachment of the film dressing is released. This can lead to
irritation of and damage to the skin, especially for patients with
a sensitive skin, for example patients aged over 70 years, children
aged under 3 years, and patients with certain illnesses, such as
eczema, or who are undergoing certain treatments, such as cortisone
treatment.
The silicon elastomer is very soft and possesses low surface
energy, and it adapts very well to the skin, that is to say it
flows out into any unevennesses in the skin and creates a large
contact surface between the skin and the silicon elastomer. This
large contact surface helps the silicon elastomer to become
attached securely to the skin, in spite of the fact that the
strength of the adhesive attachment of the silicon elastomer to the
skin is not in itself so strong. The adhesive strength constitutes
a measure of the energy required in order to separate/pull off the
adhesive layer from the skin. A contributory factor to the fact
that high energy, and thus a high pulling force, are required in
order to remove the silicon elastomer from the skin, in spite of
the relatively weak strength of the adhesive attachment, is that a
lot of energy is consumed in stretching the soft silicon elastomer
before it releases from the skin. The softer and thicker the layer
of silicon elastomer, the greater the force/energy required to
remove the elastomer from the skin.
The use of a harder adhesive will require a stronger strength of
adhesive attachment in order for the pulling force to be as high as
for a softer adhesive. A strong adhesive attachment between the
skin and the adhesive can easily lead to skin cells being pulled
from the skin in conjunction with the removal of the adhesive.
Another disadvantage associated with harder adhesives is that these
are capable of flowing outwards eventually and thus increasing the
size of the contact surface with the skin, with the result that the
pulling force eventually increases, which can lead to such
adhesives eventually becoming difficult to remove from the skin.
Unlike harder adhesives, softer adhesives such as silicon
elastomers achieve their full adhesive strength all at once so that
their pulling force remains constant as time passes.
Because the characteristics of the skin vary from person to person,
the adhesive capacity of the adhesive coating to the skin naturally
also varies for different patients. The adhesive strength is also
dependent on the thickness of the soft adhesive and the mechanical
characteristics of the barrier layer. The standard methods for the
measurement of adhesion that are available today use plates of
various kinds, for example made of steel or glass, and they do not
produce values that are relevant for the measurement of the
adhesion to the skin. The values for the strength of the adhesive
attachment of an adhesive to the skin, as indicated below, must be
measured by means of a method of the kind illustrated schematically
in FIG. 2 and developed by the applicants.
Strips of a self-adhesive film dressing, for which the strength of
the adhesive attachment to the skin is to be measured, are punched
out with dimensions of 25.times.125 mm. It should be noted that all
the strips are also provided with a carrier layer on the rear side
of the film dressing. (The function of this carrier layer is to
stiffen up the strips when they are applied to the skin). The
strips are then applied to the skin on the back of healthy
volunteers. The strips are carefully smoothed into place with a
finger, and the carrier layer on the rear side of the strips is
then removed. Finally, the strips are pressed securely against the
skin for 3 seconds with the help of a sponge made of foam plastic
(42.times.182 mm, thickness=48 mm) glued securely to a steel sheet
(50.times.200 mm, thickness=1 mm). The applied pressure is
estimated at 6 kN/m.sup.2. The strips are left in place on the skin
for 2 minutes. The strips are then pulled off at a rate of 25
mm/sec, and the removal force F1 is measured. The angle of removal,
that is to say the obtuse angle that is formed between the surface
of the skin and the removed part of the strip, must be 135.degree..
The strength of the adhesive attachment of the strip to the skin is
constituted by the mean value of the force F1.
Adhesives that are suitable for use in film dressings in accordance
with the invention must exhibit a strength of adhesive attachment
of at least 0.2-3 N/25 mm in accordance with this method. The
strength of adhesive attachment is preferably 1-2.5 N/25 mm.
Adhesives in accordance with the present invention must exhibit a
softness that exceeds 10 mm measured by means of a method based on
ASTM D 937 and DIN 51580. Certain deviations, as can be appreciated
below, have been made. FIGS. 3 and 4 illustrate this modified
method of measuring the softness of an adhesive by causing a cone B
with a weight of 62.5 g to penetrate down by the effect of gravity
into a 30 mm thick test piece C of the adhesive for which the
softness is to be determined. The test piece is obtained by filling
a cylindrical glass container having an internal diameter of 60 mm
and an internal height of 35-40 mm, with adhesive to a depth of 30
mm. In the case of a silicon elastomer, it is necessary to fill a
non-cured silicon prepolymer into the container, and then to
cross-link to an elastomer in the glass cylinder. The cone used is
illustrated in FIG. 3 and has the following dimensions: a=65 mm,
b=30 mm, c=15 mm and d=8.5 mm. In the performance of the method for
measurement of the softness, the cone B is first lowered down into
a position I, as illustrated with broken lines in FIG. 4, and in
which the tip of the cone just touches the surface of the test
piece C. The cone B is then released, so that it is able to
penetrate down into the test piece C by the effect of gravity. The
number of millimeters by which the tip B of the cone has penetrated
into the test piece C after 5 seconds is measured and constitutes
the penetration value P, the value of which is greater in
proportion to the softness of the test piece. The penetration value
P represents the softness index used in the present invention. A
PNR 10 penetrometer supplied by Sommer & Runge K G, Germany is
used in the performance of the method.
It has also been found that, in the case of soft, skin friendly
adhesives, which form barriers preventing fluid from flowing
through them, fluid is capable of leaking through these barriers
via cracks in the skin, folds in the skin or other unevennesses in
the skin. This leakage can give rise to the propagation of
bacteria, which in turn can lead to wound infections.
Surprisingly, it has been found that the above-mentioned risk of
leakage can be eliminated, or at least significantly reduced, for a
skin friendly adhesive if the adhesive is sufficiently soft and
possesses a sufficiently high weight per unit area.
The method described below, known as the MHC Leakage Test, was
developed by the applicants for the purpose of determining whether
or not a film dressing is leakproof. Specimens S with a size of
30.times.30 mm and a circular hole (d=12 mm) at the centre of the
samples are punched from the dressing to be tested. A coloured test
fluid is prepared by mixing 0.2% by weight of Patentblatt V (from
VWR International, Sweden) and 0.1% by weight of Teepol Gold (from
Teepol Products, UK) with de-ionized water. An aluminium test plate
T having dimensions of 15.times.50.times.50 mm and provided with 15
milled grooves is made; see FIG. 5, which shows a plan view of the
top side of the plate, and FIG. 6, which shows a view from the side
of the plate. For a more detailed description of the form of the
grooves, see FIG. 7, which shows a cross-sectional view through a
part of the plate.
In FIG. 7, the depth of the grooves is 75 micrometers, although
other groove depths can be used if it is wished to test the
protection against leakage at cracks in the skin or folds in the
skin with other depths, for example 50 micrometers or 150
micrometers.
A specimen S is then carefully positioned centrally above the
grooves of the test plate T in such a way that no air bubbles occur
between the test plate and the specimen; see FIG. 8. No pressure
may be exerted on the sample when it is positioned against the
plate, so that, in the event that air bubbles occur, these must not
be forced away with the help of the fingers, but the sample must be
raised and repositioned, or else scrapped.
A piece of polyurethane foam (L00562-6, 1.6 mm from Rynel, Inc.,
Boothbay, Me., USA) having dimensions of 50.times.50 mm is then
placed above the sample S and the test plate T. A mangle made of
metal (44 mm wide, r=48 mm, weight=995 g) is then rolled over the
foam and the specimen at a speed of 5 mm/second; see FIG. 9. The
mangle is rolled back and forth once over the sample.
The piece of foam is removed from the sample S, and 65 .mu.l of the
test fluid are placed in the hole on the specimen with the help of
a pipette. The test fluid is distributed uniformly in the hole with
the help of the tip of the pipette, so that the fluid reaches every
point on the edge of the sample. A stop watch is started as soon as
all the test fluid is uniformly distributed in the hole. After 30
minutes, a picture is taken with a digital camera of the specimen S
and the test fluid T placed on the test plate together with a
calibrated ruler.
The photograph is used to measure the following distances. For all
the grooves that are in contact with the hole on the sample, that
is to say in all the grooves into which fluid may be expected to
penetrate, the distance d from the edge next to the hole to the
edge on the end of the sample is measured; see FIG. 10, which
indicates this distance d1 for one of the grooves. All these
distances d are then added together, and they constitute the total
distance for which it is possible for the sample to leak. After
this, the distance e for which the test fluid has leaked in all the
grooves on the plate is measured; see FIG. 11, which shows the
distance e1 for one of the grooves. The combined length of all the
distances e represents the total leakage distance.
Finally, the leakage is obtained by dividing the combined leakage
distance e by the total distance d for which it is possible for the
sample to leak. This quotient is then converted into a percentage
figure by multiplying it by 100. The evaluation of the sealing is
performed as follows: Result>10% leakage, regarded as leakage.
Result.ltoreq.10% leakage, regarded as sealing.
Note that, between each measurement performed on the test plate,
the plate must be cleaned in the following way. The plate is first
rinsed with water, and it is then washed with n-heptane. It is
important to ensure that no adhesive residues remain in the grooves
on the plate, and a soft material of the nonwoven compress type
(Mesoft.RTM., Molnlycke Health Care) can be dipped in n-heptane and
used to rub away adhesive residues in the grooves on the plate.
Finally, the plate must be left to dry in the air before it can be
reused.
Other solvents may be used for adhesives that are not soluble in
n-heptane.
The reason why the test piece should be studied for a time after
application is that any leakage will take place by means of
capillary action, which means that it may be difficult to determine
whether or not the test piece is leakproof immediately after
application.
The above-mentioned test method with a groove depth of 75
micrometers in the grooves of the aluminium plate has demonstrated
that a test piece comprising a transparent polyethylene film having
a thickness of 25+/-5 micrometers with an adhesive coating of a
skin friendly adhesive having a weight per unit area of ca 50
g/m.sup.2 and a softness of ca 20 mm is leakproof in accordance
with this test. It has also been found that a test piece with such
an adhesive coating is leakproof on the normal, smooth skin of
younger and middle-aged persons. It may accordingly be necessary,
in areas of wrinkled skin, to use weights per unit area greater
than 50 g/m.sup.2 in order to ensure resistance to leakage.
The effect of the resistance to leakage on the softness and the
weight per unit area of the adhesive in the adhesive coating has
been investigated by the above method in respect of a silicon
elastomer, Silgel 612, supplied by Wacker Chemie GmbH, Germany.
In accordance with the MHC Leakage Test with a groove depth of 75
micrometers, the leakage was measured for a number of different
film dressings with different softness values and weights per unit
area for the adhesive. All the dressings were manufactured by
coating a polyurethane film with a thickness of 25.+-.5 micrometers
with Silgel 612 with different softness values and weights per unit
area. The result is shown in FIG. 18.
The results clearly indicate the existence of a link between the
softness (penetration) and the weight per unit area of the silicon
elastomer. The softer the silicon elastomer, the smaller the weight
per unit area required for sealing. The results point to the fact
that, for a sufficient number of measurements, it is possible to
produce a curve that indicates exactly the minimum weight per unit
area that is required at a given softness to ensure sealing against
the skin. The results make it clear that such a curve has a steep
incline initially, that is to say in the case of less soft
adhesives, after which it levels out. Accordingly, the relationship
between the weight per unit area and the softness is such that, in
order to achieve sealing at low weights per unit area, very soft
adhesives are required, whereas less soft adhesives require higher
weights per unit area in order to achieve sealing. It is obvious
that it is difficult, and perhaps even impossible, to achieve
fluid-tight film dressings at softness values below 10 mm. At
softness values in the order of 20 mm, a weight per unit area of 50
g/m.sup.2 may be sufficient to achieve sealing.
It should be added that all the known film dressings that were
tested were found to leak.
As can be appreciated from FIG. 18, certain points coincide because
a number of the tested film dressings had approximately the same
weights per unit area and softness values.
Apart from increasing the resistance to leakage, a higher weight
per unit area for the adhesive coating is associated with a reduced
risk of blisters, pimples or other damage occurring on the skin at
the edges of the applied adhesive. Such damage can arise in
conjunction with movements in the film dressing carrier, which lead
to relative movement between the skin and the adhesive coating, or
as a consequence of the dressing being subjected to external
loadings, for example in the event of the film dressing carrier
knocking against an object. It has been found that the risk of such
damage occurring is reduced with a higher weight per unit area and
a higher softness for the adhesive coating. This is presumably
attributable to the fact that a proportion of the loading is
absorbed by the adhesive layer through deformation and is not
transmitted to the skin in this way. The film dressing in
accordance with the invention is also capable of stretching
together with the skin, which reduces the risk of shearing
occurring between the skin and the adhesive that can give rise to
mechanical damage to the skin.
In order to ensure that only a low application force is required in
conjunction with the application of film dressings in accordance
with the present invention, it is recommended that the softness of
the soft, skin friendly adhesive that is used should be greater
than 10 mm, and that it should preferably lie between 12 and 17 mm.
The softer an adhesive, the more rapidly it will flow into any
unevennesses in the substrate, which means that the film dressings
in accordance with the present invention are leakproof immediately
after their application to normal skin. At a softness value greater
than 17 mm, there is a risk of the inner cohesion of the adhesive
being too low, so that residues of adhesive are left behind on the
skin in conjunction with the removal of an applied film
dressing.
Another important characteristic of a film dressing in accordance
with the invention is that the strength of adhesive attachment of
the soft, skin friendly adhesives that are used in these dressings
does not change with time or changes only to a minor degree with
time. This has been verified by measuring the strength of adhesive
attachment to the skin for a number of known film dressings and a
film dressing in accordance with the invention containing silicon
elastomer as an adhesive. The known film dressings were
Tegaderm.TM. from 3M Health Care, USA; OpSite.TM. IV3000.TM. and
OpSite.TM. Flexigrid.TM. from Smith & Nephew Medical Limited,
England. Measurement was carried out by means of the method
described above for the measurement of the strength of adhesive
attachment to the skin, with the difference that the measurements
were performed after 1 minute, 10 minutes and 3 hours. The results
are shown in FIG. 19. As can be appreciated from this Figure, the
strength of adhesive attachment increased steeply with time for the
known film dressings, whereas the dressing in accordance with the
invention exhibited in principle unchanged adhesion. In numerical
terms, the strength of adhesive attachment from 1 minute to 3 hours
increased by 295% for OpSite.TM. Flexigrid.TM., 209% for
Tegaderm.TM. and 318% for OpSite.TM. IV3000.TM..
The strength of adhesive attachment to steel for the corresponding
dressings and the Mefilm.RTM. dressing from Molnlycke Health Care
AB, Sweden was also measured by means of the method described
below.
Specimens having dimensions of 25.times.120 mm are punched from the
test material. Pieces of paper having dimensions of 25.times.250 mm
are punched from copying paper. A steel plate (in accordance with
ASTM A 666-94 A, 50.times.200 mm) is washed with a lint-free
absorbent material saturated in n-heptane, and three washes are
performed with this solvent. Finally, a final wash is performed
with acetone instead of n-heptane. The steel plate is then left to
dry for at least 10 minutes, but for not longer than 10 h. The
piece of paper is attached to the specimen at one end against the
adhesive, and the piece of paper is stapled in place using a
stapler. The important consideration is for the paper to be
attached to the specimen so securely that it is not able to slide
off in conjunction with the application of a load. The overlap
between the specimen and the piece of paper must be 10-15 mm; see
FIG. 15 (view from the side). The specimen is then placed against
the clean steel plate with the adhesive facing down towards the
steel plate. It is important for the specimen to be laid carefully
onto the steel plate in such a way that no pressure is applied to
the specimen. A piece of polyurethane foam (L00562-6, 1.6 mm from
Rynel, Inc., Boothbay, Me., USA) is then placed above the sample on
the test plate, and the sample is attached to the plate by rolling
a mangle (45 mm wide, weight=445 g, r=47 mm) back and forth once
over the piece of foam 1 at a speed of 5 mm/second; see FIG. 16
(view from the side). The specimen is tested after 1 minute or 1
hour after rolling with the mangle.
The test is performed as follows. The steel plate is clamped
securely to the lower clamp of the tensile testing machine (Instron
4301, Instron 4464 or equivalent), so that the piece of paper hangs
vertically downwards. The piece of paper is then folded upwards
through 180 degrees and is clamped securely to the upper clamp of
the tensile testing machine; see FIG. 17 (view from the side). The
tensile testing machine is started, and the mean force required to
pull the specimen from the steel plate is recorded. The tensile
testing machine must operate at a speed of 300 mm/min.
The mean force for the different film dressings was measured after
1 minute and 1 hour. The strength of adhesive attachment increased
by 22% for Tegaderm.TM., by 58% for Mefilm.RTM., by 37% for
OpSite.TM. IV3000.TM. and by 27% for OpSite.TM. Flexigrid.TM. after
one hour, whereas no increase in the strength of adhesive
attachment was measured for the film dressing in accordance with
the invention.
Furthermore, no hairs are pulled out when removing film dressings
provided with soft, skin friendly adhesive.
The products proposed in the present invention are normally
supplied packed in sterile conditions, which means that the
adhesives used must be capable of being sterilized, as must other
components of such articles, of course.
The described embodiment of the invention can naturally be modified
within the scope of the invention. Types of carrier layer other
than the plastic layer described here can be used, for example
carrier layers made of paper. It is also possible to apply an
absorption body to the dressing in order to produce a so-called
island dressing. It is also conceivable to apply different
substances to the adhesive, for example ZnO, skin care substances
or bactericidal substances, which substances are so arranged as to
leak out slowly onto the skin. It is also possible to supply
hydrophilic particles or similar in the adhesive. Moreover, the
film may be perforated with one or more holes or may be slotted.
The invention must accordingly only be restricted by the content of
the following Patent Claims.
* * * * *
References